{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:08:31Z","timestamp":1764688111981},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The work was supported by grant from the Science and Technology Project of Shanghai Municipal Science and Technology Commission","award":["No.22Y31900500"],"award-info":[{"award-number":["No.22Y31900500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The management of locally recurrent gynecological carcinoma remains a challenge due to the limited availability of data. This study aims to share our institutional experience in using definitive radiotherapy (RT) for the treatment of locally recurrent cervical and endometrial carcinoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study retrospectively reviewed 20 patients in our hospital completing salvage 3D image-based HDR brachytherapy, with or without EBRT, for locally recurrent cervical and endometrial carcinoma after surgery. The Kaplan\u2013Meier method was applied to estimate the disease-free survival (DFS) and overall survival (OS). The toxicities were assessed by CTCAEv5.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During a median observation period of 21 months, the study reported a tumor objective response rate of 95%. The 3-year DFS and OS rates were 89.4% and 90.9%, respectively. The EBRT combined with brachytherapy achieved a median cumulative dose of 88\u00a0Gy to CTV D90. 14 patients received concurrent and\/or systemic chemotherapy. Two patients suffered locoregional recurrence after salvage treatment, one of whom only received salvage brachytherapy for prior RT history. The analysis identified significant predictors for DFS, including tumor histology and FIGO stage. 5 patients observed acute grade 1\u20132 rectal (15%) or genitourinary (10%) toxicities. Late toxicities including grade 1\u20132 rectal bleeding (10%) and grade 2 pelvic fracture (5%) were seen in 3 patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>3D image-guided brachytherapy combined with EBRT shows effective tumor control and acceptable toxicity profile for women with locally recurrent gynecologic cancer. The success in managing vaginal recurrence is notably influenced by histologic subtype and FIGO staging.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12617-8","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T07:02:42Z","timestamp":1721372562000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Salvage radiotherapy for locally recurrent cervical and endometrial carcinoma: clinical outcomes and toxicities"],"prefix":"10.1186","volume":"24","author":[{"given":"Hui","family":"Cong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaobin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"issue":"1","key":"12617_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"12617_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ygyno.2021.10.075","volume":"163","author":"WQ He","year":"2021","unstructured":"He WQ, Li C. Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends. Gynecol Oncol. 2021;163(3):583\u201392. https:\/\/doi.org\/10.1016\/j.ygyno.2021.10.075.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"12617_CR3","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, Arbyn M, Basu P, Bray F, Vaccarella S. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11(2):e197\u2013206. https:\/\/doi.org\/10.1016\/S2214-109X(22)00501-0.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"12617_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/AOG.0000000000004676","volume":"139","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, Broaddus RR, Jemal A, Siegel RL. The changing Landscape of Gynecologic Cancer Mortality in the United States. Obstet Gynecol. 2022;139(3):440\u20132. https:\/\/doi.org\/10.1097\/AOG.0000000000004676.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"12617_CR5","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1200\/JCO.19.03012","volume":"38","author":"S Uppal","year":"2020","unstructured":"Uppal S, Gehrig PA, Peng K, Bixel KL, Matsuo K, Vetter MH, Davidson BA, Cisa MP, Lees BF, Brunette LL, et al. Recurrence rates in patients with cervical Cancer treated with Abdominal Versus minimally invasive radical hysterectomy: a multi-institutional Retrospective Review study. J Clin Oncol. 2020;38(10):1030\u201340. https:\/\/doi.org\/10.1200\/JCO.19.03012.","journal-title":"J Clin Oncol"},{"key":"12617_CR6","doi-asserted-by":"publisher","unstructured":"Zhang YF, Fan Y, Zhang P, Ruan JY, Mu Y, Li JK. Cervical Cancer recurrence and patient Survival after Radical Hysterectomy followed by either adjuvant chemotherapy or adjuvant Radiotherapy with Optional Concurrent Chemotherapy: a systematic review and Meta-analysis. Front Oncol. 2022;12823064. https:\/\/doi.org\/10.3389\/fonc.2022.823064.","DOI":"10.3389\/fonc.2022.823064"},{"issue":"2","key":"12617_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ygyno.2022.02.024","volume":"165","author":"F Siegenthaler","year":"2022","unstructured":"Siegenthaler F, Lindemann K, Epstein E, Rau TT, Nastic D, Ghaderi M, Rydberg F, Mueller MD, Carlson J, Imboden S. Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification. Gynecol Oncol. 2022;165(2):230\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2022.02.024.","journal-title":"Gynecol Oncol"},{"key":"12617_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ygyno.2022.11.012","volume":"168","author":"A Akesson","year":"2023","unstructured":"Akesson A, Adok C, Dahm-Kahler P. Recurrence and survival in endometrioid endometrial cancer - a population-based cohort study. Gynecol Oncol. 2023;168:127\u201334. https:\/\/doi.org\/10.1016\/j.ygyno.2022.11.012.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"12617_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1046\/j.1525-1438.1993.03040193.x","volume":"3","author":"GM Thomas","year":"1993","unstructured":"Thomas GM, Dembo AJ, Myhr T, Black B, Pringle JF, Rawlings G. Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery. Int J Gynecol Cancer. 1993;3(4):193\u20138. https:\/\/doi.org\/10.1046\/j.1525-1438.1993.03040193.x.","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"12617_CR10","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.brachy.2017.07.002","volume":"16","author":"CH Chapman","year":"2017","unstructured":"Chapman CH, Maghsoudi K, Littell RD, Chen LM, Hsu IC. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy. Brachytherapy. 2017;16(6):1152\u20138. https:\/\/doi.org\/10.1016\/j.brachy.2017.07.002.","journal-title":"Brachytherapy"},{"issue":"1","key":"12617_CR11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.clon.2021.09.012","volume":"34","author":"R Engineer","year":"2022","unstructured":"Engineer R, Chopra S, Shukla R, Mahantshetty U, Phurailatpam R, Ghadi Y, Gupta S, Shrivastava SK. Computed tomography-based interstitial brachytherapy for recurrent cervical carcinoma in the vaginal apex. Clin Oncol (R Coll Radiol). 2022;34(1):e1\u20136. https:\/\/doi.org\/10.1016\/j.clon.2021.09.012.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"12617_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.brachy.2013.09.009","volume":"13","author":"U Mahantshetty","year":"2014","unstructured":"Mahantshetty U, Shrivastava S, Kalyani N, Banerjee S, Engineer R, Chopra S. Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience. Brachytherapy. 2014;13(4):337\u201342. https:\/\/doi.org\/10.1016\/j.brachy.2013.09.009.","journal-title":"Brachytherapy"},{"key":"12617_CR13","doi-asserted-by":"publisher","unstructured":"Itami J, Murakami N, Watanabe M, Sekii S, Kasamatsu T, Kato S, Hirowatari H, Ikushima H, Ando K, Ohno T, et al. Combined interstitial and Intracavitary High-Dose Rate Brachytherapy of Cervical Cancer. Front Oncol. 2021;11809825. https:\/\/doi.org\/10.3389\/fonc.2021.809825.","DOI":"10.3389\/fonc.2021.809825"},{"issue":"6","key":"12617_CR14","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.brachy.2014.06.004","volume":"13","author":"L Fokdal","year":"2014","unstructured":"Fokdal L, Ortoft G, Hansen ES, Rohl L, Pedersen EM, Tanderup K, Lindegaard JC. Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer. Brachytherapy. 2014;13(6):554\u201361. https:\/\/doi.org\/10.1016\/j.brachy.2014.06.004.","journal-title":"Brachytherapy"},{"issue":"1","key":"12617_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.radonc.2014.08.038","volume":"113","author":"JA Vargo","year":"2014","unstructured":"Vargo JA, Kim H, Houser CJ, Berhane H, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Comerci JT, Huang M, et al. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification. Radiother Oncol. 2014;113(1):126\u201331. https:\/\/doi.org\/10.1016\/j.radonc.2014.08.038.","journal-title":"Radiother Oncol"},{"issue":"5","key":"12617_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.brachy.2016.06.010","volume":"15","author":"K Huang","year":"2016","unstructured":"Huang K, D\u2019Souza D, Patil N, Velker V, Leung E, Stitt L, Whiston F, Sugimoto A, McGee J, Prefontaine M. High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma. Brachytherapy. 2016;15(5):543\u20138. https:\/\/doi.org\/10.1016\/j.brachy.2016.06.010.","journal-title":"Brachytherapy"},{"issue":"5","key":"12617_CR17","first-page":"2413","volume":"36","author":"N Murakami","year":"2016","unstructured":"Murakami N, Kato T, Miyamoto Y, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, et al. Salvage high-dose-rate interstitial brachytherapy for pelvic recurrent cervical Carcinoma after Hysterectomy. Anticancer Res. 2016;36(5):2413\u201321.","journal-title":"Anticancer Res"},{"issue":"6","key":"12617_CR18","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.brachy.2017.07.007","volume":"16","author":"SC Kamran","year":"2017","unstructured":"Kamran SC, Manuel MM, Catalano P, Cho L, Damato AL, Lee LJ, Schmidt EJ, Viswanathan AN. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer. Brachytherapy. 2017;16(6):1159\u201368. https:\/\/doi.org\/10.1016\/j.brachy.2017.07.007.","journal-title":"Brachytherapy"},{"issue":"7","key":"12617_CR19","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/ijgc-2021-002536","volume":"31","author":"G Alban","year":"2021","unstructured":"Alban G, Cheng T, Adleman J, Buzurovic I, Pretz J, Singer L, King M, Lee L. Definitive radiotherapy for vaginal recurrence of early-stage endometrial cancer: survival outcomes and effect of mismatch repair status. Int J Gynecol Cancer. 2021;31(7):1007\u201313. https:\/\/doi.org\/10.1136\/ijgc-2021-002536.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"12617_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.brachy.2021.12.010","volume":"21","author":"LJ Lee","year":"2022","unstructured":"Lee LJ, Alban GM, Cheng T, Buzurovic I, Pretz J, Singer L, King MT. Clinical outcomes and dosimetric predictors of toxicity for re-irradiation of vaginal recurrence of endometrial cancer. Brachytherapy. 2022;21(3):263\u201372. https:\/\/doi.org\/10.1016\/j.brachy.2021.12.010.","journal-title":"Brachytherapy"},{"issue":"3","key":"12617_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ygyno.2014.01.043","volume":"132","author":"JM Noh","year":"2014","unstructured":"Noh JM, Park W, Kim YS, Kim JY, Kim HJ, Kim J, Kim JH, Yoon MS, Choi JH, Yoon WS, et al. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13\u2009\u2013\u200910). Gynecol Oncol. 2014;132(3):618\u201323. https:\/\/doi.org\/10.1016\/j.ygyno.2014.01.043.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"12617_CR22","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/IGC.0000000000001009","volume":"27","author":"EJ Jung","year":"2017","unstructured":"Jung EJ, Byun JM, Kim YN, Lee KB, Sung MS, Kim KT, Jeong DH. Cervical adenocarcinoma has a poorer prognosis and a higher propensity for distant recurrence than squamous cell carcinoma. Int J Gynecol Cancer. 2017;27(6):1228\u201336. https:\/\/doi.org\/10.1097\/IGC.0000000000001009.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"12617_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.prro.2020.04.002","volume":"10","author":"J Chino","year":"2020","unstructured":"Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch K, Harkenrider MM, Holschneider CH, Kamrava M, et al. Radiation Therapy for Cervical Cancer: executive summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2020;10(4):220\u201334. https:\/\/doi.org\/10.1016\/j.prro.2020.04.002.","journal-title":"Pract Radiat Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12617-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12617-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12617-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T07:03:34Z","timestamp":1721372614000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12617-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12617"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12617-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the institutional ethics committee of Shanghai Sixth People\u2019s Hospital, and the need to obtain informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"871"}}